STAT - Reporting from the frontiers of health and medicine

Biotech

Don't Miss

By STAT

Health Tech

By Amitha Kalaichandran

Biotech FDA documents point to a broadened approval for Amarin’s heart pill Vascepa
First Opinion Should employers take a chance on little-known Embarc to pay for gene therapy?
Health Tech Google partners with major U.S. health system, gaining access to vast patient data in the process
In the Lab Long-neglected gene plays a bigger role in Alzheimer’s than suspected, study shows
Biotech Solid Biosciences’ Duchenne gene therapy trial halted after patient suffers serious toxicity

Daily, market-moving coverage of biotech and pharma

Inside intelligence on the NIH, the FDA, and Congress

Profiles of the power players shaping the industry

Analysis of the latest scientific developments

How much? Pharma copay cards are increasing costs for private Canadian insurers
FDA admits it goofed when granting orphan status to an opioid addiction treatment
Pharmalittle: Biotechs worry about Democrats’ drug pricing bill; PhRMA criticizes four countries over policies

Special Report

Special Report

Heavyweights

Health

Health

Health

By Brittany Flaherty

Biotech It’s tiny biotechs — not big drug makers — that fear ‘nuclear winter’ from Pelosi’s drug pricing bill
Health Ebola vaccine approved in Europe in landmark moment in fight against a deadly disease
Health Tech Google partners with major U.S. health system, gaining access to vast patient data in the process
First Opinion Should employers take a chance on little-known Embarc to pay for gene therapy?
In the Lab Long-neglected gene plays a bigger role in Alzheimer’s than suspected, study shows